tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Wittes, 80 are a BUY (86.02%), 13 are a HOLD (13.98%).
Analyst Jason Wittes, carries an average stock price target met ratio of 65.86% that have a potential upside of 49.3% achieved within 355 days. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.
Jason Wittes’s has documented 179 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SYK, Stryker at 02-May-2025.
Analyst best performing recommendations are on PGNX (PROGENICS PHARMACEUTICALS).
The best stock recommendation documented was for BWAY (BRAINSWAY LTD) at 8/10/2023. The price target of $5.5 was fulfilled within 104 days with a profit of $2.8 (103.7%) receiving and performance score of 9.97.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4
$2.92 (270.37%)
$7
3 months 18 days ago
(06-Nov-2025)
0/3 (0%)
$2.78 (227.87%)
Buy
$9
$7.92 (733.33%)
2 years 11 days ago
(13-Feb-2024)
0/3 (0%)
$6.25 (227.27%)
Buy
$10
$8.92 (825.93%)
$10
4 years 3 months 29 days ago
(26-Oct-2021)
0/5 (0%)
$5.7 (132.56%)
Hold
$4.25
$3.17 (293.52%)
$4
6 years 7 months 14 days ago
(10-Jul-2019)
3/3 (100%)
$0.59 (16.12%)
99
What Year was the first public recommendation made by Jason Wittes?
